Form4insider filings, from the source

SEC Form 4 · accession 0001193805-15-000427

SteadyMed Ltd. · STDY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
DEERFIELD MANAGEMENT CO
10% Owner · Other
Deerfield Mgmt L.P.
10% Owner · Other
James E Flynn
10% Owner · Other
Deerfield Mgmt III, L.P.
10% Owner · Other
Period of report
Mar 25, 2015
Accepted (ET)
Mar 25, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001619087

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2,F3Mar 25, 2015C265,089—A265,089IThrough Deerfield Private Design Fund III, L.P.
Ordinary SharesF1,F2,F3Mar 25, 2015C265,089—A265,089IThrough Deerfield Special Situations Fund, L.P.
Ordinary SharesF2,F3Mar 25, 2015P179,115$8.50A444,204IThrough Deerfield Private Design Fund III, L.P.
Ordinary SharesF2,F3Mar 25, 2015P558,440$8.50A823,529IThrough Deerfield Special Situations Fund, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Preferred StockF1,F2,F3—Mar 25, 2015C34,205D——Ordinary Shares265,0890I
Series E Preferred StockF1,F2,F3—Mar 25, 2015C34,205D——Ordinary Shares265,0890I

Explanation of responses

Remarks

Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to Avalanche Biotechnologies, Inc. filed with the Securities and Exchange Commission on July 30, 2014 by Deerfield Mgmt III, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P., Deerfield Private Design Fund III, L.P. and James E. Flynn.